Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vispero is the world's leading assistive technology provider for the visually impaired, offering a comprehensive suite of hardware and software solutions designed to enhance independence and accessibility. Formed through the merger of industry pioneers Freedom Scientific and Optelec, the company later expanded its portfolio by acquiring Enhanced Vision and Ai Squared. Its flagship products include the JAWS screen reader, ZoomText magnification software, and a wide range of video magnifiers and braille displays. Vispero serves a global community of blind and low-vision individuals, providing tools for education, employment, and daily living. The company operates under several well-known brands and maintains a presence in over 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VFO.